16 questions answered from cited research · Plain language
Research shows that women with perinatal depression have measurable brain changes compared to healthy controls, including reduced activity in regulatory areas and increased activity in emotional centers.
Read the full answer →Perinatal depression affects 20.1% to 25.8% of women in Ethiopia based on pooled meta-analysis, with individual studies reporting rates up to 32.2%.
Read the full answer →Yes, polygenic risk scores for major depression show stronger associations with comorbid anxiety-depression cases than with depression alone, indicating a shared genetic link.
Read the full answer →Technical factors (e.g., blood collection time, season) and behavioral factors (e.g., BMI, smoking, exercise) can significantly influence blood biomarker levels, potentially affecting depression-related results.
Read the full answer →No specific blood biomarkers have been validated to predict major depression outcomes in UK Biobank; research is ongoing.
Read the full answer →A 2024 systematic review found that psychedelic-assisted therapy does not show a clear advantage over traditional antidepressants for treating major depression when both are compared in open-label trials.
Read the full answer →Yes, multiple meta-analyses show aerobic exercise significantly reduces postpartum depressive symptoms and improves quality of life, with moderate to large effect sizes.
Read the full answer →Yes, the FDA approved Zurzuvae (zuranolone) on August 4, 2023, for treating postpartum depression in adults.
Read the full answer →Postpartum depression involves altered brain activity in regions like the amygdala, precuneus, and occipital gyrus, linked to neurotransmitter systems and emotional regulation.
Read the full answer →Yes, a 2026 randomized trial found auricular acupressure with five-element music therapy significantly reduced labor pain and postpartum depression at 1 week.
Read the full answer →Yes, a 2024 trial found that preoperative pain education before cesarean section significantly reduced postpartum depression incidence (2.5% vs 12.5%).
Read the full answer →Yes, genetic testing can help understand treatment-resistant depression in Pakistan by identifying CYP2C19 gene variants that affect antidepressant metabolism, as shown in a large Pakistani study [3].
Read the full answer →Yes, intensive short-term dynamic psychotherapy (ISTDP) shows large and lasting effects on depression in treatment-resistant depression, with benefits maintained up to 18 months.
Read the full answer →Early research shows gut bacteria differ in people with bipolar disorder and depression, but it's too soon to say whether changing gut bacteria can manage symptoms.
Read the full answer →Yes, mind-body exercise (like yoga, tai chi, qigong) can significantly reduce depressive symptoms in cancer patients, based on a large network meta-analysis and other studies.
Read the full answer →The cognitive triad (negative views of self, world, future) is strongly linked to depressive symptoms, with depressive symptoms often predicting a more negative triad over time.
Read the full answer →